Picture of Brainsway logo

BWAY Brainsway Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Annual cashflow statement for Brainsway, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-6.46-13.3-4.22.927.58
Depreciation
Non-Cash Items4.652.961.071.43-1.48
Unusual Items
Other Non-Cash Items
Changes in Working Capital1.01-0.9013.084.189.86
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities0.884-9.761.2810.317.5
Capital Expenditures-2.24-2.39-3.79-2.34
Purchase of Fixed Assets
Other Investing Cash Flow Items-4042.2-3534.1-15.1
Sale of Fixed Assets
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities-42.242.2-37.430.3-17.5
Financing Cash Flow Items-0.269-0.962-0.755-1.11-0.877
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities41.5-1.55-1.0318.3-1.71
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.0430.7-37.158.8-1.65